Stockreport

Oculis to Participate in Upcoming Investor Conferences

Oculis Holding AG  (OCS) 
PDF ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused [Read more]